KR20220154196A - 연질겔 캡슐 - Google Patents

연질겔 캡슐 Download PDF

Info

Publication number
KR20220154196A
KR20220154196A KR1020227035608A KR20227035608A KR20220154196A KR 20220154196 A KR20220154196 A KR 20220154196A KR 1020227035608 A KR1020227035608 A KR 1020227035608A KR 20227035608 A KR20227035608 A KR 20227035608A KR 20220154196 A KR20220154196 A KR 20220154196A
Authority
KR
South Korea
Prior art keywords
acid
softgel capsule
softgel
gelatin
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227035608A
Other languages
English (en)
Korean (ko)
Inventor
리키 스티브 셸리
Original Assignee
알.피.쉐러 테크놀러지즈 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알.피.쉐러 테크놀러지즈 엘엘씨 filed Critical 알.피.쉐러 테크놀러지즈 엘엘씨
Publication of KR20220154196A publication Critical patent/KR20220154196A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
KR1020227035608A 2020-03-18 2021-03-18 연질겔 캡슐 Pending KR20220154196A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062991354P 2020-03-18 2020-03-18
US62/991,354 2020-03-18
PCT/US2021/022918 WO2021188773A1 (en) 2020-03-18 2021-03-18 Softgel capsules

Publications (1)

Publication Number Publication Date
KR20220154196A true KR20220154196A (ko) 2022-11-21

Family

ID=77771391

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227035608A Pending KR20220154196A (ko) 2020-03-18 2021-03-18 연질겔 캡슐

Country Status (11)

Country Link
US (1) US20230172864A1 (https=)
EP (1) EP4121036A4 (https=)
JP (2) JP7785682B2 (https=)
KR (1) KR20220154196A (https=)
AR (1) AR121608A1 (https=)
AU (1) AU2021238345A1 (https=)
BR (1) BR112022018268A2 (https=)
CA (1) CA3171512A1 (https=)
CO (1) CO2022014130A2 (https=)
MX (1) MX2022011549A (https=)
WO (1) WO2021188773A1 (https=)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133939A1 (en) * 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
EP1545477A4 (en) * 2002-09-13 2006-11-22 Cydex Inc CAPSULES CONTAINING AQUEOUS FILLING COMPOSITIONS STABILIZED WITH DERIVED CYCLODEXTRIN
ITMI20022777A1 (it) * 2002-12-27 2004-06-28 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
EP2444071A1 (en) * 2004-09-27 2012-04-25 Sigmoid Pharma Limited Minicapsule formulations
CN1872061A (zh) * 2006-04-17 2006-12-06 宛六一 一种药物组合物软胶囊及其制备方法
JP5840668B2 (ja) * 2012-12-07 2016-01-06 富士カプセル株式会社 ロキソプロフェンナトリウム含有軟カプセル用内容物、及び、それを含有する軟カプセル製剤
US10420729B2 (en) * 2013-03-15 2019-09-24 R.P. Scherer Technologies, Llc Abuse resistant capsule
US9326947B1 (en) * 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
US9775814B2 (en) * 2014-06-20 2017-10-03 Patheon Softgels Inc. Enteric soft capsule compositions
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
ES2787220T3 (es) * 2015-03-26 2020-10-15 Patheon Softgels Inc Cápsulas blandas llenas de líquido
US20180049999A1 (en) * 2015-04-14 2018-02-22 Atossa Genetics Inc. Compositions and methods of treatment of breast disorders and estrogen-related disorders
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
IL316439A (en) * 2018-03-15 2024-12-01 Scherer Technologies Llc R P Enteric softgel capsules
IT201800003615A1 (it) * 2018-03-15 2019-09-15 Altergon Sa Formulazioni altamente stabili di ormone tiroideo in capsule molli

Also Published As

Publication number Publication date
EP4121036A4 (en) 2024-04-10
CO2022014130A2 (es) 2022-10-31
US20230172864A1 (en) 2023-06-08
EP4121036A1 (en) 2023-01-25
JP2023518245A (ja) 2023-04-28
MX2022011549A (es) 2022-10-13
JP2026035788A (ja) 2026-03-04
BR112022018268A2 (pt) 2022-10-25
AU2021238345A1 (en) 2022-10-06
AR121608A1 (es) 2022-06-22
JP7785682B2 (ja) 2025-12-15
WO2021188773A1 (en) 2021-09-23
CA3171512A1 (en) 2022-09-23

Similar Documents

Publication Publication Date Title
JP7558204B2 (ja) 遅延放出ソフトゲルカプセル
JP7628537B2 (ja) より高いｐｈ環境における遅延放出ソフトゲルカプセル
EP3768094B1 (en) Enteric softgel capsules
KR20230106641A (ko) 지연 방출 소프트겔 캡슐
JP7443266B2 (ja) 腸溶性ソフトゲルカプセル剤
KR20230106642A (ko) 지연 방출 소프트겔 캡슐
KR20230018445A (ko) 지연 방출 소프트겔 캡슐
JP7785682B2 (ja) ソフトゲルカプセル
RU2789789C2 (ru) Энтеросолюбильные капсулы из мягкого желатина
RU2828673C1 (ru) КАПСУЛЫ ЗАДЕРЖАННОГО ВЫСВОБОЖДЕНИЯ ИЗ МЯГКОГО ЖЕЛАТИНА В СРЕДЕ С БОЛЕЕ ВЫСОКИМ ЗНАЧЕНИЕМ pH
US20240165041A1 (en) Softgel Capsule and Method of Marking a Softgel Capsule
RU2815635C2 (ru) Энтеросолюбильные капсулы из мягкого желатина
JP2026500927A (ja) ソフトゲルカプセル及びソフトゲルカプセルを調製するための方法
JP2025527319A (ja) コーティングされた腸溶性ソフトゲルカプセル剤
BR112020018255B1 (pt) Cápsulas softgel entéricas e seu método de produção

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20221013

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application